FIELD: medicine.
SUBSTANCE: medicine with wound healing activity is produced on the base of supernantant of human fibroblasts and it additionally contains human plasma O (I) of Rh-positive, group, regular insulin, natrium nuclinate, amino acid complex Inphezol 100, fat concentrate Lipofundin MST/LST 20%, salts, glucose and vitamins.
EFFECT: high-efficiency complex medicine with wound healing activity without any agents prohibited for clinical use.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTANCE POSSESSING ANTI-INFLAMMATORY, IMMUNOMODULATING AND WOUND-HEALING ACTIVITY | 2005 |
|
RU2300384C2 |
| METHOD FOR LOCAL TREATMENT OF EROSIVE-ULCEROUS DEFECTS OF SKIN AND MUCOSA | 2003 |
|
RU2250108C2 |
| CELLGEL WOUND HEALING PRODUCT, METHOD FOR PREPARING IT AND METHOD FOR HEALING OF WOUNDS OF VARIOUS AETHIOLOGIES BY PREPARED PRODUCT | 2011 |
|
RU2481115C1 |
| METHOD OF TREATMENT OF CORNEAL ULCERS | 2006 |
|
RU2324488C1 |
| AGENT FOR STIMULATION OF CELLS PROLIFERATION, COMPOSITE FOR STIMULATION OF CELLS PROLIFERATION AND METHOD FOR TREATMENT OF WOUNDS, BURNS AND ULCERS OF DIFFERENT ETIOLOGY | 2001 |
|
RU2214256C2 |
| DRUG FOR ACCELERATION OF THE HEALING OF THE PURULENT WOUNDS, CONTAINING CHLORIDE RUBIDIUM IN THE FORM OF SOLUTION | 2018 |
|
RU2681531C1 |
| CHRONIC WOUND AND/OR WOUND CHAMBER HEALING TECHNIQUE | 2012 |
|
RU2512681C2 |
| WOUND HEALING PRODUCT IN THE FORM OF AN OINTMENT CONTAINING RUBIDIUM CHLORIDE | 2019 |
|
RU2722127C1 |
| METHOD OF TREATING DEEP STROMAL KERATITES | 2010 |
|
RU2440801C1 |
| METHOD FOR TREATING TROPHIC SKIN DISORDERS IN PATIENTS WITH SEVERE BRAIN DAMAGE | 2020 |
|
RU2752747C1 |
